Triple-negative breast cancer (TNBC), which is characterized by the lack of estrogen/progesterone-receptor (ER/PR) and human epidermal growth factor receptor-2 (HER-2), accounts for 15 to 20% of all BC cases [2]. The gene discussed is PGR; the disease is breast cancer.